KitoZyme

• President Ascencio SCA
• Administrator Quality Assistance

The companies in which he either is active or was up until recently active range from SMEs and spin-offs, such as OncoDNA, NANOCYL and Delphi GENETICS, which are active in the technology, medical or healthcare sectors to major listed companies, including RECTICEL or Compagnie du BOIS SAUVAGE and public authorities, such as AWEX, AMONIS or BioWIN.

As an entrepreneur, he has (co)founded several start-ups and gained broad experience in the management of innovation–driven companies. He began his career in the chemical sector with assignments both in the United States and in Europe. In 1999, he joined International Brachytherapy, an oncology medical device start-up. He served as CEO, leading IBt, an NYSE-Euronext stock listed company, from its R&D stage to a successful and well-diversified international group that became a European leader in its market segment.

In 1995, Gery Lefebvre graduated in Business Administration from HEC-ULg and immediately started his career in Credit Management with Atradius and later in Corporate Banking at HSBC in Paris. In 2002, he obtained a post-graduate Master in Taxation from HEC-ULg. Following this, he moved to Albemarle Europe where he was responsible for Treasury Management and Working Capital Optimization. From 2009 – 2014, he was the CFO of Belgian Advanced Technology Systems SA

As Chairman of the Board of the federal investment company, he contributed recently to anchor and invest in strategic assets and sectors in the country to the benefit of the economy and to the citizen. He also been appointed as expert to several Belgian governmental steering groups on industrialization, innovation, exportation and Brexit. Working closely with Universities and high schools, he’s also involved in different academic initiatives.

Mr. Fellin specializes in Biotech companies, spin-offs and SMEs that are active in the healthcare and industrial sectors.